ACL australian clinical labs limited

Results decent but shows the executive have not done a good job...

  1. 176 Posts.
    lightbulb Created with Sketch. 180
    Results decent but shows the executive have not done a good job of setting guidance reasonably. Underlying growth in revenue is good, but just have to tighten a little on NPAT. Assuming the heat coming out of wages I would assume better cost control moving forward.

    honestly pathology in this country is a bit of a cash cow. Management should be keeping it tight and getting ready for the next outbreak to manifest.

    buying at this price, but a little side-eye at the board TBH.

    cheers,

    YS
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.82
Change
-0.015(0.53%)
Mkt cap ! $549.8M
Open High Low Value Volume
$2.83 $2.83 $2.78 $1.158M 414.6K

Buyers (Bids)

No. Vol. Price($)
15 13291 $2.81
 

Sellers (Offers)

Price($) Vol. No.
$2.82 17864 26
View Market Depth
Last trade - 14.32pm 29/07/2025 (20 minute delay) ?
ACL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.